CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
CLN-049-001 is a Phase 1/2, open-label, multicenter, first-in-human trial of CLN-049 in patients with Relapsed/Refractory Acute Myeloid...
Phase 1, Phase 2
Phoenix, Arizona, United States and 16 other locations
allogeneic hematopoietic stem cell transplant (HCT), versus Conventional Care in patients with Active, Relapsed or Refractory Acute Myeloid...
Phase 3
Gilbert, Arizona, United States and 23 other locations
Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML...
Phase 3
Gilbert, Arizona, United States and 133 other locations
\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...
Phase 3
Phoenix, Arizona, United States and 89 other locations
Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML...
Phase 1
Phoenix, Arizona, United States and 43 other locations
will be evaluated in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML). The main study has ...
Phase 1, Phase 2
Gilbert, Arizona, United States and 43 other locations
The purpose of this study is to assess if adding revumenib to standard chemotherapy improves outcomes in participants with AML with certain ...
Phase 3
Goodyear, Arizona, United States and 172 other locations
This is a two Part study in patients with relapsed/refractory acute myeloid leukemia (AML), chronic myelomonocyti...
Phase 1, Phase 2
Gilbert, Arizona, United States and 7 other locations
VEN+AZA alone for the treatment of participants with newly diagnosed Acute Myeloid Leukemia (AML) with a mutation...
Phase 3
Goodyear, Arizona, United States and 269 other locations
This is a multi-center, randomized, double-blinded, placebo controlled trial.
Phase 3
Gilbert, Arizona, United States and 111 other locations
Clinical trials
Research sites
Resources
Legal